APA (7th ed.) Citation

H, T., V, P., N, K., N, M., U, B., C, M., . . . M, L. (2024). LMS-based continuous pediatric reference values for soluble receptor activator of nuclear factor kappa B ligand (sRANKL) and osteoprotegerin (OPG) in the HARP cohort. Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 35(3), 533. https://doi.org/10.1007/s00198-023-06959-5

Chicago Style (17th ed.) Citation

H, Tietze, et al. "LMS-based Continuous Pediatric Reference Values for Soluble Receptor Activator of Nuclear Factor Kappa B Ligand (sRANKL) and Osteoprotegerin (OPG) in the HARP Cohort." Osteoporosis International : A Journal Established as Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 35, no. 3 (2024): 533. https://doi.org/10.1007/s00198-023-06959-5.

MLA (9th ed.) Citation

H, Tietze, et al. "LMS-based Continuous Pediatric Reference Values for Soluble Receptor Activator of Nuclear Factor Kappa B Ligand (sRANKL) and Osteoprotegerin (OPG) in the HARP Cohort." Osteoporosis International : A Journal Established as Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, vol. 35, no. 3, 2024, p. 533, https://doi.org/10.1007/s00198-023-06959-5.